Image 1_Identification of immune subtypes associated with CD8+ T cell-related genes providing new treatment strategies of esophageal carcinoma.pdf by Youyi Wu (20786402)

“…</p>Conclusions<p>Collectively, we identified the immune subtypes of CD8+ T cell-related genes with different prognostic significance. …”

Image 3_Identification of immune subtypes associated with CD8+ T cell-related genes providing new treatment strategies of esophageal carcinoma.pdf by Youyi Wu (20786402)

“…</p>Conclusions<p>Collectively, we identified the immune subtypes of CD8+ T cell-related genes with different prognostic significance. …”

Image 4_Identification of immune subtypes associated with CD8+ T cell-related genes providing new treatment strategies of esophageal carcinoma.pdf by Youyi Wu (20786402)

“…</p>Conclusions<p>Collectively, we identified the immune subtypes of CD8+ T cell-related genes with different prognostic significance. …”

Image 5_Identification of immune subtypes associated with CD8+ T cell-related genes providing new treatment strategies of esophageal carcinoma.pdf by Youyi Wu (20786402)

“…</p>Conclusions<p>Collectively, we identified the immune subtypes of CD8+ T cell-related genes with different prognostic significance. …”

Table 1_The burden and etiologies of diarrhea in Asia and its countries from 1990 to 2021 and the forecast to 2040: analyses informed by the global burden of disease study 2021.doc... by Shan Liu (193759)

“…The incidence and prevalence rates in 0–9 years old and 90+ years old and the DALY rates and mortality rates in all age groups in 2021 were decreased compared with 1990. Temporal joinpoint analysis revealed that after 2019, the age-standardized incidence rate (ASIR) of diarrhea exhibited a significant upward trend in Asia and some Asian countries. …”

Table 5_The burden and etiologies of diarrhea in Asia and its countries from 1990 to 2021 and the forecast to 2040: analyses informed by the global burden of disease study 2021.doc... by Shan Liu (193759)

“…The incidence and prevalence rates in 0–9 years old and 90+ years old and the DALY rates and mortality rates in all age groups in 2021 were decreased compared with 1990. Temporal joinpoint analysis revealed that after 2019, the age-standardized incidence rate (ASIR) of diarrhea exhibited a significant upward trend in Asia and some Asian countries. …”

Table 2_The burden and etiologies of diarrhea in Asia and its countries from 1990 to 2021 and the forecast to 2040: analyses informed by the global burden of disease study 2021.doc... by Shan Liu (193759)

“…The incidence and prevalence rates in 0–9 years old and 90+ years old and the DALY rates and mortality rates in all age groups in 2021 were decreased compared with 1990. Temporal joinpoint analysis revealed that after 2019, the age-standardized incidence rate (ASIR) of diarrhea exhibited a significant upward trend in Asia and some Asian countries. …”

Data Sheet 1_The burden and etiologies of diarrhea in Asia and its countries from 1990 to 2021 and the forecast to 2040: analyses informed by the global burden of disease study 202... by Shan Liu (193759)

“…The incidence and prevalence rates in 0–9 years old and 90+ years old and the DALY rates and mortality rates in all age groups in 2021 were decreased compared with 1990. Temporal joinpoint analysis revealed that after 2019, the age-standardized incidence rate (ASIR) of diarrhea exhibited a significant upward trend in Asia and some Asian countries. …”

Table 4_The burden and etiologies of diarrhea in Asia and its countries from 1990 to 2021 and the forecast to 2040: analyses informed by the global burden of disease study 2021.doc... by Shan Liu (193759)

“…The incidence and prevalence rates in 0–9 years old and 90+ years old and the DALY rates and mortality rates in all age groups in 2021 were decreased compared with 1990. Temporal joinpoint analysis revealed that after 2019, the age-standardized incidence rate (ASIR) of diarrhea exhibited a significant upward trend in Asia and some Asian countries. …”

Table 3_The burden and etiologies of diarrhea in Asia and its countries from 1990 to 2021 and the forecast to 2040: analyses informed by the global burden of disease study 2021.doc... by Shan Liu (193759)

“…The incidence and prevalence rates in 0–9 years old and 90+ years old and the DALY rates and mortality rates in all age groups in 2021 were decreased compared with 1990. Temporal joinpoint analysis revealed that after 2019, the age-standardized incidence rate (ASIR) of diarrhea exhibited a significant upward trend in Asia and some Asian countries. …”

Table 1_Evaluating the Implementation of fan-beam CT-guided online adaptive re-planning in definitive cervical cancer radiotherapy.docx by Shuai Sun (775057)

“…For OARs, the adaptive plan achieved reductions in the dose to the most irradiated 2 cm³ volume (D2cc) for the rectum, bladder, and small intestine (P<0.001). For patients with ovarian conservation, the dose to the 50% volume (D50) and the mean dose of the bilateral ovaries were decreased (P<0.001). …”

Data Sheet 2_Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma.pdf by Robert B. Rebhun (8479020)

“…Cytotoxicity assays of PBMCs showed significant decreases after both surgery and chemotherapy with an overall decrease from the start to end of therapy (-18.2 ± 16.1%, P<0.001). …”

Data Sheet 1_Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma.pdf by Robert B. Rebhun (8479020)

“…Cytotoxicity assays of PBMCs showed significant decreases after both surgery and chemotherapy with an overall decrease from the start to end of therapy (-18.2 ± 16.1%, P<0.001). …”

<b>Contrasting strategies, shared risk: 12-yr nitrogen addition compromises hydraulic safety in young and mature trees via distinct pathways</b> by Shijie Ning (17757825)

“…We found that, in young trees, N50 decreased soluble sugars in leaves, twigs, and branches, but increased in roots, suggesting a preferential belowground allocation, whereas N20 responses were limited. …”

Table 1_The real-world safety of Nivolumab: a pharmacovigilance analysis based on the FDA adverse event reporting system.docx by Yutong Wu (3130584)

“…Notably, we detected several potential safety signals not currently listed in the prescribing information: Malignant neoplasm progression, weight decreased, sepsis myocarditis, encephalitis and hypotension.…”

Data Sheet 1_Cytosolic phospholipase A2 links tau pathology to insulin signaling impairment in Alzheimer’s disease.pdf by Faruk Hossen (20275670)

“…Specifically, we found significant decreases in insulin receptor-α (IR-α) and insulin receptor-β (IR-β) expression, along with increased levels of phospho-insulin receptor substrate 1 at Ser307 [p-IRS-1 (Ser307)] and decreased levels of p-IRS-1 (Tyr895), compared to wild-type (WT) mice. …”

Table 1_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

“…Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a significant decrease in tumor cell proliferation was observed across multiple cancer models.…”

Image 2_Changes in the gut microbiome due to diarrhea in neonatal Korean indigenous calves.jpeg by Ji-Yeong Ku (20832209)

“…However, Proteobacteria increased and Bacteroidetes and Actinobacteria decreased in calves with diarrhea. In addition, calves with diarrhea showed a significant decrease in the diversity of the gut microbiome, especially for anaerobic microorganisms Faecalibacterium prausnitzii, Gemmiger formicilis, and Collinsella aerofaciens. …”

Table 5_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

“…Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a significant decrease in tumor cell proliferation was observed across multiple cancer models.…”

Table 4_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

“…Furthermore, when HMGB2 knockdown was combined with Palbociclib treatment, a significant decrease in tumor cell proliferation was observed across multiple cancer models.…”